NCT06275269

Endoscopic Mucosal Injection Versus Ultrasound-Guided Injection of Triamcinolone to Treat Subglottic Stenosis

Comparison of the Safety and Economics of Translaryngeal Endoscopic Mucosal Injection Versus Ultrasound-Guided Injection of Triamcinolone for the Treatment of Subglottic Stenosis: a Multicenter, Randomized Controlled Study.

• Status: Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 40 (estimated)
• Sponsor: China-Japan Friendship Hospital · Academic / Other
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

This study employs a multicenter, randomized controlled trial method, where patients meeting the inclusion criteria for subglottic stenosis are randomly divided into two groups. These groups are respectively undergoing translaryngeal endoscopic mucosal injection and ultrasound-guided injection of triamcinolone treatment. The comparison will focus on various indicators such as therapeutic effect, incidence of adverse reactions, treatment costs, and hospital resource utilization between the two groups. The safety and effectiveness will be compared to determine the relative merits of the two treatment methods.

Conditions

• Subglottic Stenosis

Interventions

Type	Name	Description
PROCEDURE	Ultrasound-Guided	Ultrasound-Guided Triamcinolone Injection
PROCEDURE	Translaryngeal Endoscopic Mucosal Injection	Translaryngeal Endoscopic Mucosal Injection of Triamcinolone

Timeline

• Start date: 2024-03-10
• Primary completion: 2025-10-31
• Completion: 2025-12-31
• First posted: 2024-02-23
• Last updated: 2025-02-10

Locations

1 site across 1 country: China